OUR MISSION is to serve pharmaceutical clients that provide cures and treatments for gastro-entrological diseases including: gallstones, PBC, PSC and NASH.

News

ICE GROUP acquires Iwaki manufacturing site from Mitbubishi API corporation

We are pleased to announce that on May 2nd ICE Group completed the purchase of the Iwaki Ursodeoxycholic Acid (“UDCA”) manufacturing site from Mitsubishi API Corporation. This transaction represents the end of an acquisition process that started in October 2021.

Tokyo Tanabe was the originally developer of…

ICE GROUP acquires ABC Farmaceutici S.p.A.

We are pleased to announce that on December 15th ICE Group completed the acquisition of ABC Farmaceutici S.p.A (“ABC”). ABC is a pharmaceutical company based in Ivrea, Italy. Founded in 1925, the company is dedicated to the research, development,…

ICE Group Cogenerator Project in Basaluzzo manufacturing site

In May 2019 the cogenerator project was ended and realized. Project was supported by POS FESR PIEMONTE 2014-2020.

The principal goals of the project were:

   - reduction of energy costs derived from the large use of electricity and steam in production processes.

   - the company's conversion…

ABOUT ICE GROUP

ICE Group is a globally integrated business that produces ingredients for the pharmaceutical industry. Our main product is Ursodeoxycholic Acid (UDCA), a key ingredient in drugs treating liver conditions.

Founded more than sixty years ago, ICE Group is a global leader in bile-related products, with a network of specialist facilities around the world.

  1. 1949

    ICE’s first plant was opened in Reggio Emilia, Italy (production of Cholic Acid and bile acids derivatives)

  2. 1996

    BBA Industria Quimica (former Opoterapica) founded in Paranà, Brazil (collection of ox bile and its transformation in raw Cholic Acid)

  3. 1999

    Acquisition of RPT Texas, USA (collection and concentration of ox bile)

  4. 2003

    Opening of Arennis in Argentina (collection and concentration of ox bile)

  5. 2004

    Opening of Walfed Pty in Australia (collection and concentration of ox bile)

  6. 2008

    Acquisition of PCA, a major manufacturer of UDCA and derivative in Italy

    Opening of PBP in Paraguay (collection and concentration of ox bile)

  7. 2010

    Opening of CVF in Uruguay (collection and concentration of ox bile)

  8. 2014

    Opening of the Des Moines plant in the USA (collection and concentration of pig bile)

  9. 2015

    Acquisition of RIAZ in Italy (collection and concentration of ox bile and pig bile)

  10. 2016

    Opening of Raichem (a 50% Joint Venture started in India)

  11. 2018

    Raichem becomes a fully owned subsidiary

  12. 2019

    Advent International acquires ICE Group 

OUR HISTORY

ICE Group was established in 1949 by husband-and-wife team Dr Walter and Ida Bartoli. From our humble origins in Northern Italy, we have grown organically and through acquisitions into the company we are today.

Our Footprint

We have a vertically integrated model from sourcing to pharma grade production.

IceItaly - world map

IceItaly - blue bookmark

BILE
COLLECTION

Europe, US, Latin America, South
Africa, India, Australia

IceItaly - pink bookmark

CHOLIC ACID
PRODUCTION

Brazil

IceItaly - green bookmark

API
PRODUCTION

Italy, New Zealand, India

Our facilities

As well as being the number-one player in the manufacture of UDCA, we also produce a comprehensive range of bile acid derivatives as well as other products we have developed.

ice

Production plants, Italy

NZP Logo

Production plant, New Zealand

bba

Bile extraction plant
and Cholic Acid
production,
Brazil

raichem

Production plant, India

Dextra Logo

Custom Carbohydrate Synthesis & Manufacture, UK

riaz

Processing plant, Piacenza, Italy

roth

Processing plants in, Texas & Iowa, USA

arenniscvf pbp

Bile extraction plants, Agentina, Uruguay & Paraguay

Our values

IceItaly - Quality

QUALITY IN
EVERYTHING
WE DO

IceItaly - Safety

SAFETY
ABOVE ALL

IceItaly - Respect

TREAT
EVERYBODY
WITH RESPECT

IceItaly - Innovation

innovation
FOR OUR
CLIENTS AND
PATIENTS